Wynn Capital’s Pfizer PFE Stock Holding History

Wynn Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$916K	Buy	32,109 +405	+1%	+$10.8K	0.41%	56
2026 Q2	$763K	Buy	31,704 +85	+0.3%	+$2.22K	0.34%	57
2026 Q1	$888K	Buy	31,619 +720	+2%	+$19.2K	0.46%	53
2025 Q4	$769K	Sell	30,899 -6,360	-17%	-$160K	0.37%	58
2025 Q3	$949K	Buy	37,259 +820	+2%	+$20.2K	0.46%	52
2025 Q2	$883K	Buy	36,439 +160	+0.4%	+$3.73K	0.47%	52
2025 Q1	$919K	Buy	36,279 +14,220	+64%	+$372K	0.55%	48
2024 Q4	$585K	Sell	22,059 -955	-4%	-$25.9K	0.37%	60
2024 Q3	$666K	Buy	23,014 +2,000	+10%	+$58.3K	0.44%	58
2024 Q2	$588K	Buy	21,014 +1,285	+7%	+$35.4K	0.43%	56
2024 Q1	$547K	Sell	19,729 -1,694	-8%	-$47K	0.42%	59
2023 Q4	$617K	Buy	+21,423	New	+$648K	0.5%	52

Other funds holding PFE

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Wynn Capital's PFE Position: Q3 2026 in Review

Wynn Capital increased its Pfizer (PFE) stake by 1.3% in Q3 2026, buying an estimated $10.8K and bringing the position to 32,109 shares worth $916K. The position accounts for 0.41% of the portfolio, ranked #56.

Wynn Capital first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $949K in Q3 2025. 1,861 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Wynn Capital held 32,109 shares of Pfizer worth $916K as of Q3 2026.
Wynn Capital bought 405 Pfizer shares in Q3 2026, an estimated $10.8K.
Pfizer made up 0.41% of Wynn Capital's portfolio in Q3 2026, its #56 holding.
Wynn Capital first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
Wynn Capital's Pfizer position peaked at $949K in Q3 2025.
1,861 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Wynn Capital's 13F filing for Q3 2026, filed 13 Oct 2026.